Fifty-six human ovarian tumor samples checked by immunohistochemistry showed that CD8+ CTL density is significantly decreased in patients with a poor survival rate and associated with significantly higher expression of CAF markers (Figure 1E). The gene discussed is CD8A; the disease is ovarian neoplasm.